Patents by Inventor JungJe Joo

JungJe Joo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compound as protein kinase inhibitor
    Patent number: 8957102
    Abstract: Provided are novel heterocyclic compounds useful as anti-cancer drugs by suppressing protein kinase activities of growth factor receptors such as c-Met, pharmaceutical compositions containing the same, and methods for using the compound.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: February 17, 2015
    Assignee: Neopharm Co., Ltd.
    Inventors: Tae-Seong Kim, Eunkyung Lee, Doyoung Kim, Bu-mahn Park, Jiyeon Park, JungJe Joo
  • HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR
    Publication number: 20120289509
    Abstract: Provided are novel heterocyclic compounds useful as anti-cancer drugs by suppressing protein kinase activities of growth factor receptors such as c-Met, pharmaceutical compositions containing the same, and methods for using the compound.
    Type: Application
    Filed: July 6, 2012
    Publication date: November 15, 2012
    Applicant: NEOPHARM CO., LTD.
    Inventors: Tae-Seong KIM, Eunkyung LEE, Doyoung KIM, Bu-mahn PARK, Jiyeon PARK, JungJe JOO
  • HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR
    Publication number: 20110183983
    Abstract: Provided are novel heterocyclic compounds useful as anti-cancer drugs by suppressing protein kinase activities of growth factor receptors such as c-Met, pharmaceutical compositions containing the same, and methods for using the compound.
    Type: Application
    Filed: August 28, 2009
    Publication date: July 28, 2011
    Applicant: NEOPHARM CO., LTD.
    Inventors: Tae-Seong Kim, Eunkyung Lee, Doyoung Kim, Bu-mahn Park, Jiyeon Park, JungJe Joo